Abstract
Background
: Inhibition of cyclooxygenase-2 with a reduction of prostaglandin E2production by the specific antagonist NS-398 has been shown to have beneficial effects on immune function and survival in a trauma model. Immune fuction after experimental hemorrhagic shock and subsequent sepsis may be gender-related, with enhanced immunity and better survival in females. However, it remains unclear if the observed effect of NS-398 treatment is gender-related following hemorrhagic shock and subsequent sepsis.
Methods
: Male and female CBA/J mice (age: 2-3 months) were subjected to hemorrhagic shock (35 ± 5 mm Hg for 90 min and fluid resuscitation) or sham operation. At resuscitation and after 20 and 40 h each received either NS-398 10 mg/kg or placebo i.p. At 48 h after resuscitation, either splenocytes and peritoneal macrophages (pMϕ) were harvested (n = 8 per group), or polymicrobial sepsis was induced by cecal ligation and puncture (CLP). Following CLP, either 10-day survival (n = 15 per group) was determined or pM ϕ and splenocytes were harvested 4 h after CLP (n = 8 per group). Cytokine release of pMϕ, and splenocyte proliferation and responsiveness in vitro were assessed.
Results
: Treatment with NS-398 led to lower PGE2 levels as compared to placebo-treated animals, reaching significance (p < 0.05) in males. Placebo-treated males had significantly depressed proinflammatory immune response (IL-1, IL-6, IL-2, IFN-γ) after hemorrhagic shock and experienced further suppression by CLP (all, p < 0.05). In contrast, young females displayed unchanged cytokine release after hemorrhagic shock, but a comparable suppression following CLP. Treatment with NS-398 did not influence cytokine release nor survival.
Conclusions
: Despite a significant reduction of PGE2 concentration, NS-398 treatment has no beneficial effects on cytokine release and survival in this model of hemorrhage and subsequent sepsis.
Get full access to this article
View all access options for this article.